M. Fradette et al., SERUM THEOPHYLLINE PROFILE WITH ONCE-DAILY THEOPHYLLINE (UNIPHYL) FOLLOWING CONVERSION FROM INTRAVENOUS THEOPHYLLINE IN ADULT ASTHMATIC-PATIENTS, Clinical therapeutics, 16(2), 1994, pp. 160-168
Although guidelines are available for conversion from intravenous (IV)
theophylline to twice-daily, oral, controlled-release theophylline, t
he optimal method for conversion to Uniphyl(R), a chronotherapeuticall
y formulated, once-daily theophylline preparation, has not been previo
usly evaluated. The present study was designed to prospectively evalua
te a method for converting patients from IV theophylline to Uniphyl, t
o formulate simple, practical dosage recommendations for use in clinic
al practice. Ten patients with acute exacerbation of asthma receiving
IV theophylline for greater-than-or-equal-to 48 hours and with steady
state serum theophylline concentrations (STCs) between 4.5 and 15.5 mg
/L (25 and 86 mumol/L) were enrolled into the study. Patients with STC
s greater-than-or-equal-to 4.5 and < 12 mg/L (greater-than-or-equal-to
25 and <66 mumol/L) and those with STCs greater-than-or-equal-to 12 a
nd less-than-or-equal-to 15.5 mg/L (greater-than-or-equal-to 66 and le
ss-than-or-equal-to 86 mumol/L) received their first Uniphyl dose imme
diately following termination of IV theophylline (No Time Lapse [NTL'
group) and after a 4-hour delay (Time Lapse [TL] group), respectively.
The differences in the area under the curve values between Uniphyl do
sing and IV theophylline were 11% in the NTL group (1214.6 +/- 247.9 m
umol/h . L-1 vs 1370.4 +/- 148.1 mumol/h . L-1, 95% confidence interva
l, 74% to 103%; P = 0.068) and 10% in the TL group (1959.4 +/- 165.1 m
umol/h . L-1 vs 1784.6 +/- 119.4 mumol/h . L-1, 95% confidence interva
l, 103% to 117%; P = 0.013). The results suggest that patients with ST
Cs less-than-or-equal-to 15.5 mg/L (less-than-or-equal-to 86 mumol/L)
may be safely converted from IV to oral theophylline by giving the fir
st Uniphyl dose immediately on discontinuation of the infusion, or aft
er a 4-hour delay, based on the prevailing theophylline concentration.